T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Vail Resorts
MTN
$5.21B
| $1.12B | 0.18% |
5,270,989
+107,530
| +2% | +$24.1M |
|
127
Kraft Heinz
KHC
$29.6B
| $1.09B | 0.18% |
14,076,635
+3,450,004
| +32% | +$271M |
|
128
CVS Health
CVS
$122B
| $1.09B | 0.18% |
15,086,080
+6,320,630
| +72% | +$460M |
|
129
Burlington
BURL
$23.4B
| $1.08B | 0.18% |
8,794,777
-445,687
| -5% | -$45.4M |
|
130
Hilton Worldwide
HLT
$70B
| $1.08B | 0.18% |
13,533,242
-895,472
| -6% | -$66.4M |
|
131
Air Products & Chemicals
APD
$68.6B
| $1.08B | 0.17% |
6,567,877
+50,305
| +0.8% | +$8.01M |
|
|
SPLK
132
DELISTED
Splunk Inc
SPLK
| $1.07B | 0.17% |
12,923,521
+3,104,315
| +32% | +$228M |
|
133
O'Reilly Automotive
ORLY
$74.6B
| $1.07B | 0.17% |
66,669,135
-38,806,470
| -37% | -$578M |
|
134
Keysight
KEYS
$57.3B
| $1.06B | 0.17% |
25,582,342
+2,227,613
| +10% | +$96.2M |
|
|
HES
135
DELISTED
Hess
HES
| $1.06B | 0.17% |
22,372,235
+116,561
| +0.5% | +$5.26M |
|
|
SAGE
136
DELISTED
Sage Therapeutics
SAGE
| $1.04B | 0.17% |
6,311,317
+1,643,958
| +35% | +$159M |
|
137
MetLife
MET
$61.7B
| $1.03B | 0.17% |
20,292,208
-4,736,241
| -19% | -$249M |
|
138
Delta Air Lines
DAL
$58.7B
| $1.02B | 0.17% |
18,173,697
+6,976,991
| +62% | +$364M |
|
139
Revvity
RVTY
$12.9B
| $1.02B | 0.17% |
13,905,996
+1,331,055
| +11% | +$95.5M |
|
140
CF Industries
CF
$18.4B
| $1B | 0.16% |
23,572,534
-1,304,284
| -5% | -$49.2M |
|
141
Stanley Black & Decker
SWK
$15.5B
| $995M | 0.16% |
5,861,468
+1,409,940
| +32% | +$231M |
|
142
Equity Residential
EQR
$24.7B
| $994M | 0.16% |
15,583,902
+237,305
| +2% | +$15.8M |
|
143
Ferrari
RACE
$71.5B
| $987M | 0.16% |
9,410,267
-3,037,899
| -24% | -$338M |
|
144
TotalEnergies
TTE
$195B
| $977M | 0.16% |
1,619,819,684
-191,998,880
| -11% | -$115M |
|
145
Bruker
BRKR
$8.58B
| $975M | 0.16% |
28,418,579
-83,602
| -0.3% | -$2.74M |
|
146
IDEX
IEX
$17.2B
| $968M | 0.16% |
7,335,829
-383,361
| -5% | -$49.3M |
|
|
SCHW
147
Charles Schwab
SCHW
$187B
| $968M | 0.16% |
18,841,840
-38,925
| -0.2% | -$1.83M |
|
148
Weyerhaeuser
WY
$18.2B
| $945M | 0.15% |
26,796,627
-940,578
| -3% | -$33.3M |
|
149
KeyCorp
KEY
$24.3B
| $926M | 0.15% |
45,928,035
+3,106,790
| +7% | +$58.6M |
|
150
West Pharmaceutical
WST
$24.8B
| $919M | 0.15% |
9,309,447
-81,042
| -0.9% | -$7.95M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.